Pou1f1-KO Mouse
Common Name
Pou1f1-KO
제품 ID
S-KO-17690
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-18736-Pou1f1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Pou1f1-KO Mouse (카탈로그 번호 S-KO-17690)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Pou1f1-KO
품종 계통계통 ID
KOCMP-18736-Pou1f1-B6J-VA
유전자명
제품 ID
S-KO-17690
유전자 별칭
dw, Hmp1, Pit1, GHF-1, Pit-1, dwarf, Pit1-rs1
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 16
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000176330
NCBI 전사체 ID
NM_008849
타겟 영역
Exon 4~5
유효 영역 크기
~2.0 kb
유전자 연구 개요
POU1F1, also known as POU Class 1 Homeobox1, is a pituitary-specific transcription factor. It plays a crucial role in the development and function of the anterior pituitary gland, regulating the expression of genes encoding growth hormone (GH), thyroid-stimulating hormone (TSH), and prolactin. It is involved in pathways related to growth, metabolism, and endocrine regulation, and its normal function is essential for overall physiological homeostasis. Genetic models, such as mouse models, are valuable for studying its functions [2,3,4,5,6].
Mice carrying the Pou1f1 c.143-83A>G substitution, which recapitulates a human intronic variant, showed postnatal growth failure, anterior pituitary hypoplasia, and deficiencies in circulating insulin-like growth factor 1 and thyroxine. RNA-seq and immunohistochemical analyses confirmed a reduction in somatotrophs. Reverse transcription polymerase chain reaction of pituitary Pou1f1 mRNA showed abnormal splicing, with changes in the ratios of alpha and beta isoforms and the emergence of an exon-skipped transcript [2]. In humans, POU1F1 mutations are prevalent in Indian combined pituitary hormone deficiency (CPHD) cohorts. Patients with these mutations often have severe GH, TSH, and prolactin deficiencies. Phenotype-genotype analysis revealed that patients with heterozygous mutations have milder phenotypes, including higher mean peak-GH levels and lower prevalence of anterior-pituitary hypoplasia compared to those with homozygous and compound heterozygous mutations [1]. Some patients with POU1F1 mutations also present with central precocious puberty or early puberty, although the relationship between the genotype and these pubertal phenotypes has not been firmly established. Animal studies suggest that the Pou1f1 gene may affect GnRH receptor function and the Gata2 gene, and control gonadotrope evolution [3].
In conclusion, POU1F1 is essential for the normal development and function of the anterior pituitary gland, regulating key hormones involved in growth and metabolism. Mouse models with specific Pou1f1 mutations have provided insights into the role of this gene in postnatal growth, pituitary development, and endocrine function. In humans, POU1F1 mutations are associated with CPHD and some pubertal abnormalities, highlighting the gene's significance in understanding these disease conditions [1,2,3].
References:
1. Jadhav, Swati, Diwaker, Chakra, Lila, Anurag R, Shah, Nalini S, Bandgar, Tushar R. 2021. POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature. In Pituitary, 24, 657-669. doi:10.1007/s11102-021-01140-9. https://pubmed.ncbi.nlm.nih.gov/33742319/
2. Akiba, Kazuhisa, Hasegawa, Yukihiro, Katoh-Fukui, Yuko, Fukami, Maki, Narumi, Satoshi. . POU1F1/Pou1f1 c.143-83A > G Variant Disrupts the Branch Site in Pre-mRNA and Leads to Dwarfism. In Endocrinology, 164, . doi:10.1210/endocr/bqac198. https://pubmed.ncbi.nlm.nih.gov/36427334/
3. Baş, Firdevs, Abalı, Zehra Yavaş, Toksoy, Güven, Uyguner, Zehra Oya, Darendeliler, Feyza. 2018. Precocious or early puberty in patients with combined pituitary hormone deficiency due to POU1F1 gene mutation: case report and review of possible mechanisms. In Hormones (Athens, Greece), 17, 581-588. doi:10.1007/s42000-018-0079-4. https://pubmed.ncbi.nlm.nih.gov/30460459/
4. Gangat, Mariam, Radovick, Sally. 2017. Pituitary Hypoplasia. In Endocrinology and metabolism clinics of North America, 46, 247-257. doi:10.1016/j.ecl.2017.01.003. https://pubmed.ncbi.nlm.nih.gov/28476222/
5. Bosch I Ara, Laura, Katugampola, Harshini, Dattani, Mehul T. 2021. Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome. In Frontiers in pediatrics, 8, 600962. doi:10.3389/fped.2020.600962. https://pubmed.ncbi.nlm.nih.gov/33634051/
6. Bando, Hironori, Brinkmeier, Michelle L, Castinetti, Frederic, Brue, Thierry, Camper, Sally A. . Heterozygous variants in SIX3 and POU1F1 cause pituitary hormone deficiency in mouse and man. In Human molecular genetics, 32, 367-385. doi:10.1093/hmg/ddac192. https://pubmed.ncbi.nlm.nih.gov/35951005/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
